Radiology Podcast | RSNA

Episoder

• 
  How CT-based Screening Is Redefining Prevention 21.07.2026 17min

  Host Dr. Celina Nahyun Jo sits down with Dr. Perry Pickhardt to explore how opportunistic CT screening is transforming routine imaging into a powerful tool for cardiometabolic risk assessment, bone health evaluation, liver disease detection, and body composition analysis. Together, they discuss the role of explainable AI, the future of CT-based biologic age, and why value-added imaging has the potential to reshape preventive care.   CT-based Opportunistic Screening for Adding Clinical Value:How I Do It. Pickhardt et al. Radiology 2026; 319(1):e252106.
• 
  Optimizing Radiography Utilization 14.07.2026 35min

  Dr. Linda Chu speaks with Dr. Eddy Zandee and Dr. Kirk Davis about multidisciplinary expert consensus recommendations aimed at reducing the use of low yield radiographs and improving imaging appropriateness across healthcare settings. They explore which common radiographic exams may offer limited clinical value, when CT or MRI may be more appropriate, and how education and workflow changes can help optimize imaging utilization. Optimizing Radiography Utilization: Multidisciplinary Expert Consensus Recommendations Endorsed by the Society of Academic Bone Radiologists, Society of Skeletal Radiology, American Societyof Emergency Radiology, Orthopaedic Trauma Association, American Academy of Emergency Medicine, and American Rhinologic Society. Zandee van Rilland et al. Radiology 2026; 319(2):e252309.
• 
  New Insights Into Prostate Cancer Care 07.07.2026 26min

  Dr. Ashwin Singh Parihar sits down with Dr. Louise Emmett to discuss how post-therapy Lutetium-177 PSMA SPECT/CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZA-p trial run by ANZUP cancer trials group, they explore quantitative imaging, treatment response assessment, adaptive dosing strategies, and the growing role of theranostics in precision oncology.   177Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer. Ayati et al. Radiology 2026; 319(1):e252672.
• 
  Finding the Value in AI Assistance 30.06.2026 22min

  Dr. Siddhant Dogra sits down with Dr. Su Hwan Kim to discuss how reader experience influences the performance and real world utility of large language models for brain MRI differential diagnosis. Together they explore AI assisted decision making, automation bias, radiology training, and why strong AI performance does not always translate into meaningful clinical benefit. Performing Best When Needed Least: Reader Experience ShapesAccuracy Gains in Large Language Model–assisted Brain MRIDifferential Diagnosis. Schramm et al. Radiology 2026; 319(2):e253477.  
• 
  Radiology Careers (re-release) 23.06.2026 39min

  Dr. Reni Butler discusses career advice for early, mid, and late career radiologists, mentorship, and work life integration with Dr. Stamatia Destounis and Dr. Mark Mullins. This episode was first published Oct 10, 2023
• 
  The Future of Crohn Disease Detection 09.06.2026 15min

  Dr. Linda Chu explores the latest radiology research shaping the future of Crohn's disease diagnosis and management, from revised imaging criteria for bowel strictures to emerging MR elastography techniques that better assess intestinal fibrosis. She also highlights advances in abbreviated MR enterography and practical MRI approaches for perianal fistulas, emphasizing how imaging innovation may improve patient outcomes and clinical decision making.   Revised Criterion for Identifying Small-Bowel Stricture in Crohn Disease at CT Enterography. Choi and Choi et al. Radiology 2026; 318(3):e253113.    MR Elastography Characterization of Biomechanical Properties to Enhance Enterographic Fibrosis Diagnosis. Chen and Wang et al. Radiology 2026; 318(2):e252429.    MR Elastography Biomarkers for Fibrosis in Crohn Disease Strictures. Qiu. Radiology 2026; 318(3):e250358.    Comparison of Conventional versus Abbreviated MR Enterography: Assessing Disease Activity and Complicationsin Crohn Disease. Rimola et al. Radiology 2026; 319(2):e252039.    How I Do It: MRI Approach to Perianal Fistulas. Stoker and Halligan. Radiology 2026; 319(2):e251909. 
• 
  Ultra-processed Foods and Muscle Fat 02.06.2026 20min

  Host Dr. Refky Nicola is joined by Dr. Zehra Akkaya, Dr. Gabby Joseph, and Dr. Thomas Link to explore new research connecting ultra-processed food consumption with thigh muscle fat infiltration on MRI. Together, they unpack how dietary patterns may impact muscle quality, metabolic health, and the future role of nutritional radiology in patient care.    Ultra-processed Foods and Muscle Fat Infiltration at Thigh MRI: Data from the Osteoarthritis Initiative. Akkaya et al. Radiology 2026; 319(1):e251129.
• 
  Thermal and Nonthermal Liver Ablation 26.05.2026 16min

  Dr. Linda Chu and Dr. Christos Georgiades for an in-depth look at thermal and non-thermal liver ablation, explaining how techniques like microwave ablation, cryoablation, and histotripsy work at a mechanistic level. Their conversation also explores how clinicians choose the right approach for each patient and highlights emerging advances in immunologic strategies and AI shaping the future of liver tumor treatment.   Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.  Centner et al. Radiology 2026; 318(3):e25026.   
• 
  Abbreviated MRI Insights for Breast Imaging 19.05.2026 24min

  Dr. Reni Butler speaks with Dr. Roberto Lo Gullo and Dr. Katja Pinker-Domenig about the growing role of abbreviated MRI in evaluating treatment response for breast cancer patients undergoing chemotherapy. They explore the balance between efficiency and accuracy, current limitations, and how emerging AI technologies could shape the future of breast imaging and patient care. Abbreviated MRI for the Evaluation of Treatment Response in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer. Lo Gullo et al. Radiology 2026; 319(1):e252413 
• 
  MRI for Active Surveillance in Prostate Cancer 12.05.2026 23min

  In this episode, host Dr. Refky Nicola speaks with Dr. Francesco Giganti and Dr. Alex Kirkham about how MRI is used to guide active surveillance in prostate cancer, including the role of PRECISE scoring in tracking disease progression. They share practical insights on imaging techniques, measurement challenges, and how emerging AI tools may improve consistency and decision-making in surveillance care. MRI for Active Surveillance in Prostate Cancer: How I Do It. Giganti et al. Radiology 2026; 318(3):e242164.  
• 
  Evolving Strategies for Renal Cell Carcinoma 05.05.2026 12min

  Dr. Ashwin Singh Parihar sits down with Dr. Iben Lyskjær and Dr. Tommy Kjærgaard Nielsen to unpack new nationwide registry data comparing ablation and surgical approaches for small renal masses. Together, they explore how minimally invasive treatments stack up in real-world practice and what the findings mean for patient selection, outcomes, and future care decisions. Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry Study. Ahrenfeldt et al. Radiology 2026; 318(3):e251485.
• 
  Reporting Guidelines for LLMs in Radiology 28.04.2026 13min

  Dr. Lauren Kim sits down with Dr. Jonathan Kottlors to explore how large language models are reshaping radiology research and why standardized reporting is critical for trust and reproducibility. They dive into the new FLAIR framework and what it means for the future of AI integration in clinical radiology.   Guidelines for Reporting Studies on Large Language Models in Radiology: An International Delphi Expert Survey. Kottlors and Iuga et al. Radiology 2026; 318(2):e250913.
• 
  Photon Counting CT Changes Thoracic Imaging 21.04.2026 12min

  In this episode, Dr. Linda Chu reviews new Radiology studies exploring how photon counting CT is transforming thoracic imaging with ultra‑high resolution and dramatically lower radiation and contrast doses. She examines whether these visually striking images translate into better diagnostic confidence and meaningful improvements in patient care for emphysema and lung cancer imaging.   Ultra-Low-Dose Photon-counting Detector CT for EmphysemaAssessment: A Head-to-Head Comparative Study with Low-Dose CT. Yuan and Yang et al. Radiology 2026; 318(1):e251609.   Photon-counting CT versus Energy-integrating Detector CTin Imaging Lung Cancer. Yang et al. Radiology 2026; 318(2):e251126.   Photon-counting CT versus Energy-integrating Detector CTPerformance for Various BMI and Tumor Sizes in Lung Cancer. Zhou and Guo et al. Radiology 2026; 318(2):e251663.   Prospective Evaluation of Ultra-Low-Dose Photon-counting CT inEmphysema Assessment. Schwartz. Radiology 2026; 318(2):e254065. 
• 
  Body Fat Distribution at MRI 14.04.2026 10min

  Hosted by Dr. Sid Dogra, this episode of the Radiology Podcast explores new research showing that where fat is distributed in the body—particularly visceral and organ-specific fat—may matter more for brain health than overall BMI. Drawing on a large UK Biobank MRI study, Dr. Dogra discusses how specific fat distribution patterns, including pancreatic-predominant and "skinny fat" phenotypes, are associated with accelerated brain aging, cognitive decline, and increased neurologic disease risk.   Association of Body Fat Distribution Patterns at MRI with BrainStructure, Cognition, and Neurologic Diseases. Yu and Yao et al. Radiology 2026; 318(1):e252610.
• 
  The Rise of Deepfake Medical Imaging 07.04.2026 18min

  Hosted by Dr. Ashwin Singh Parihar, this episode features Dr. Mickael Tordjman and Dr. Bachir Taouli discussing their landmark Radiology study on AI‑generated deepfake medical images that are realistic enough to fool trained radiologists. Together, they examine what this new level of image realism means for diagnostic accuracy, clinical trust, and the future of safeguards in medical imaging.   The Rise of Deepfake Medical Imaging: Radiologists' Diagnostic Accuracy in Detecting ChatGPT-generated Radiographs. Tordjman and Yuce et al. Radiology 2026; 318(3):e252094.   The Democratization of Deceit: Seeing Is No Longer Believing. Bhayana and Krishna. Radiology 2026; 318(3):e260466. 
• 
  New Look at Cervical Spine Evaluation 24.03.2026 12min

  Dr. Celina Nahyun Jo talks with Dr. Mahla Radmard about how NEXUS and the Canadian C‑Spine Rule shape cervical spine imaging decisions in trauma patients. Together they explore new research that questions long‑standing imaging practices and highlights opportunities to improve value safety and accuracy in patient care. Evaluating National Emergency X-Radiography Utilization Study and Canadian C-Spine Rule Criteria and Their Clinical Impact on Cervical Spine Imaging: Best Practice. Asadollahi and Arjmand et al. Radiology 2026; 318(1):e243834.
• 
  Incidental Adnexal Lesions 17.03.2026 9min

  Dr. Refky Nicola speaks with Dr. Atul Shinagare about his team's research showing that incidental adnexal lesions on single‑phase CT are often difficult for radiologists to classify consistently, with only certain classic lesions yielding strong agreement. Their conversation underscores the limitations of CT compared with ultrasound or MRI and reinforces that most incidental adnexal findings are benign, though many still require additional imaging for clarification. Incidental Adnexal Lesions: CT Diagnosis and Interreader Agreement. Guo et al. Radiology 2026; 318(2):e243477.   
• 
  Inside PSMA PET Frameworks 10.03.2026 17min

  Dr. Ashwin Parihar speaking with Drs. Sungmin Woo and Alberto Vargas about why standardized PSMA PET scoring systems—such as PSMA‑RADS and PROMISE—are becoming essential for consistent interpretation, communication, and treatment planning in prostate cancer. They explore the evidence behind these frameworks, current barriers to adoption, and how future harmonization efforts like the SPARC Initiative may shape the evolution of PSMA PET reporting. Navigating the Scoring Systems and Interpretation Frameworksof Prostate-specific Membrane Antigen PET. Woo and Masci et al. Radiology 2025; 317(3):e250701.  
• 
  Reassessing NSF Risk with Modern Contrast 03.03.2026 16min

  Dr. Lauren Kim speaks with Adarsh Mallepally and Dr. Cory Trankle about their large-scale retrospective study of nearly 4 million patients examining the risk of nephrogenic systemic fibrosis after gadolinium-based contrast administration in those with advanced renal dysfunction. They discuss how modern group 2 and macrocyclic agents were associated with an exceedingly low incidence of NSF, offering important reassurance for evidence-based contrast use and evolving clinical practice. Nephrogenic Systemic Fibrosis in Patients with Advanced RenalDysfunction Following Gadolinium-based Contrast Agents. Mallepally et al. Radiology 2025; 317(3):e251794.   
• 
  The New Era of Coronary CT 24.02.2026 34min

  Dr. Linda Chu speaks with Dr. Kavitha Chinnaiyan and Dr. Jonathon Leipsic about why 2026 marks an inflection point for coronary CT, from AI-enabled plaque quantification to FFR-CT and evolving guideline support for CT-first evaluation of suspected coronary artery disease. They explore how advanced imaging tools are reshaping risk assessment, personalizing prevention and revascularization decisions, and strengthening collaboration between radiology and cardiology while highlighting the need for validation, standardization, and equitable access.